Use of S1P Receptor Agonists in Heart Diseases

作者: Gilles Feutren , Robert Paul Hof , Volker Brinkmann

DOI:

关键词:

摘要: The invention relates to the use of a sphingosine-1-phosphate receptor agonist in treatment heart diseases.

参考文章(24)
Sharmila Anandasabapathy, William H. Frishman, Innovative Drug Treatments for Viral and Autoimmune Myocarditis The Journal of Clinical Pharmacology. ,vol. 38, pp. 295- 308 ,(1998) , 10.1002/J.1552-4604.1998.TB04428.X
Tadashi Miyamoto, Akira Matsumori, Myung-Woo Hwang, Ryosuke Nishio, Haruyasu Ito, Shigetake Sasayama, Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis Journal of the American College of Cardiology. ,vol. 37, pp. 1713- 1718 ,(2001) , 10.1016/S0735-1097(01)01204-9
Atsushi Sugiyama, Nu Nu Aye, Yutaka Yatomi, Yukio Ozaki, Keitaro Hashimoto, Effects of sphingosine 1-phosphate, a naturally occurring biologically active lysophospholipid, on the rat cardiovascular system. Japanese Journal of Pharmacology. ,vol. 82, pp. 338- 342 ,(2000) , 10.1254/JJP.82.338
K Lynch, Lysophospholipid receptor nomenclature. Biochimica et Biophysica Acta. ,vol. 1582, pp. 70- 71 ,(2002) , 10.1016/S1388-1981(02)00138-5
J Karliner, Lysophospholipids and the cardiovascular system. Biochimica et Biophysica Acta. ,vol. 1582, pp. 216- 221 ,(2002) , 10.1016/S1388-1981(02)00174-9
John G F Cleland, Joseph John, Jatinder Dhawan, Andrew Clark, What is the optimal medical management of ischaemic heart failure British Medical Bulletin. ,vol. 59, pp. 135- 158 ,(2001) , 10.1093/BMB/59.1.135
Shigeo Sasaki, Masahiko Yoneta, Tetsuro Fujita, Tadashi Yoshitomi Pharmac. Ind. Ltd. Mishina, Kunitomo Yoshitomi Pharmac. Ind. Ltd. Adachi, Kenji Yoshitomi Pharmac. Ind. Ltd Chiba, 2-amino-1,3-propanediol compound and immunosuppressant ,(1993)